emp Biotech

Executive Summary

emp Biotech, headquartered in Munich, Germany, is a private biotechnology company founded in 2015 that specializes in manufacturing high-quality reagents, purification resins, chromatography tools, and specialty chemicals for life sciences research and biopharmaceutical production. The company's product portfolio supports workflows from early-stage R&D to large-scale manufacturing, with a particular focus on oligonucleotide synthesis and biomolecule purification. As a supplier to the life sciences and biopharma industries, emp Biotech benefits from the growing demand for biologics and nucleic acid-based therapeutics, positioning itself as a critical enabler of drug development and production.

Upcoming Catalysts (preview)

• Q2 2026Expansion of Oligonucleotide Synthesis Product Line70% success
• H2 2026Strategic Partnership with Major Pharma for Purification Solutions50% success
• Q4 2026Entry into Asian Market via Distribution Agreement60% success